TW200300139A - Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome - Google Patents
Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome Download PDFInfo
- Publication number
- TW200300139A TW200300139A TW091132199A TW91132199A TW200300139A TW 200300139 A TW200300139 A TW 200300139A TW 091132199 A TW091132199 A TW 091132199A TW 91132199 A TW91132199 A TW 91132199A TW 200300139 A TW200300139 A TW 200300139A
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- triene
- tridecane
- formula
- ring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33481001P | 2001-10-31 | 2001-10-31 | |
| US33585801P | 2001-11-26 | 2001-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200300139A true TW200300139A (en) | 2003-05-16 |
Family
ID=26989404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW091132199A TW200300139A (en) | 2001-10-31 | 2002-10-30 | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1439836A1 (fr) |
| JP (1) | JP2005507411A (fr) |
| KR (1) | KR20050038583A (fr) |
| CN (1) | CN1568184A (fr) |
| BR (1) | BR0213696A (fr) |
| CA (1) | CA2460118A1 (fr) |
| CZ (1) | CZ2004524A3 (fr) |
| HU (1) | HUP0401967A2 (fr) |
| IL (1) | IL160967A0 (fr) |
| MX (1) | MXPA04002539A (fr) |
| PL (1) | PL370549A1 (fr) |
| SK (1) | SK1912004A3 (fr) |
| TW (1) | TW200300139A (fr) |
| WO (1) | WO2003037329A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1633358A1 (fr) * | 2003-05-20 | 2006-03-15 | Pfizer Products Inc. | Compositions pharmaceutiques a base de varenicline |
| US8114909B2 (en) | 2003-09-17 | 2012-02-14 | Xenoport, Inc. | Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| JP5129143B2 (ja) | 2005-10-07 | 2013-01-23 | エグゼリクシス， インコーポレイテッド | Ｍｅｋインヒビターおよびその使用方法 |
| CN101605540A (zh) | 2006-12-14 | 2009-12-16 | 埃克塞利希斯股份有限公司 | 使用mek抑制剂的方法 |
| PT3417862T (pt) | 2012-07-27 | 2021-08-06 | Neurodyn Life Sciences Inc | Biodisponibilidade cerebral da galantamina melhorada através de formulações selecionadas e administração transmucosal de pró-fármacos lipofílicos |
| JP6272857B2 (ja) * | 2012-07-27 | 2018-01-31 | ニューロダイン ライフ サイエンシズ インコーポレイテッドＮｅｕｒｏｄｙｎ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | 選ばれた処方物によるガランタミンの向上した脳バイオアベイラビリティおよび親油性プロドラッグの経粘膜投与 |
| SI2909188T1 (en) | 2012-10-12 | 2018-07-31 | Exelixis, Inc. | A novel process for the manufacture of compounds for use in the treatment of cancer |
| US10568852B2 (en) * | 2015-05-22 | 2020-02-25 | Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) | Combination compositions and their use in methods for treating obesity and obesity-related disorders |
| WO2018236957A1 (fr) * | 2017-06-20 | 2018-12-27 | Nexien Biopharma, Inc. | Procédé et compositions permettant de traiter le syndrome des jambes sans repos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020335A (en) * | 1997-02-06 | 2000-02-01 | Pfizer Inc | (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
| EP0955301A3 (fr) * | 1998-04-27 | 2001-04-18 | Pfizer Products Inc. | Dérivés de 7-aza-bicyclo[2.2.1]-heptane, leur préparation et utilisation sur la base d'affinité pour les recepteurs de l'acetylcholine nicotinique neuronaux |
| SK15952000A3 (sk) * | 1998-04-29 | 2002-06-04 | Pfizer Products Inc. | Aryl-anelovaná azapolycyklická zlúčenina, jej použitie a farmaceutické kompozície na jej báze |
-
2002
- 2002-10-21 HU HU0401967A patent/HUP0401967A2/hu unknown
- 2002-10-21 KR KR1020047006544A patent/KR20050038583A/ko not_active Application Discontinuation
- 2002-10-21 IL IL16096702A patent/IL160967A0/xx unknown
- 2002-10-21 EP EP02802239A patent/EP1439836A1/fr not_active Withdrawn
- 2002-10-21 JP JP2003539673A patent/JP2005507411A/ja active Pending
- 2002-10-21 CN CNA028200292A patent/CN1568184A/zh active Pending
- 2002-10-21 CZ CZ2004524A patent/CZ2004524A3/cs unknown
- 2002-10-21 BR BR0213696-1A patent/BR0213696A/pt not_active IP Right Cessation
- 2002-10-21 PL PL02370549A patent/PL370549A1/xx not_active Application Discontinuation
- 2002-10-21 SK SK191-2004A patent/SK1912004A3/sk not_active Application Discontinuation
- 2002-10-21 WO PCT/IB2002/004379 patent/WO2003037329A1/fr not_active Application Discontinuation
- 2002-10-21 MX MXPA04002539A patent/MXPA04002539A/es unknown
- 2002-10-21 CA CA002460118A patent/CA2460118A1/fr not_active Abandoned
- 2002-10-30 TW TW091132199A patent/TW200300139A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04002539A (es) | 2004-05-31 |
| JP2005507411A (ja) | 2005-03-17 |
| EP1439836A1 (fr) | 2004-07-28 |
| CN1568184A (zh) | 2005-01-19 |
| HUP0401967A2 (hu) | 2005-01-28 |
| IL160967A0 (en) | 2004-08-31 |
| CZ2004524A3 (cs) | 2004-07-14 |
| PL370549A1 (en) | 2005-05-30 |
| KR20050038583A (ko) | 2005-04-27 |
| WO2003037329A1 (fr) | 2003-05-08 |
| CA2460118A1 (fr) | 2003-05-08 |
| SK1912004A3 (en) | 2004-09-08 |
| BR0213696A (pt) | 2004-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3123897C (fr) | Derives de benzodiazepine, compositions et procedes de traitement de la deficience cognitive | |
| US20230134844A1 (en) | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | |
| US20060211686A1 (en) | Alpha7 Neuronal nicotinic receptor ligand and antipsychotic compositions | |
| HUT77315A (hu) | Loratadinszármazék allergiás és egyéb betegségek kezelésében való alkalmazásra | |
| JP2010540439A (ja) | 神経保護性の及び認知を向上させる性質を備えた水素化されたピリド［４，３−ｂ］インドール類のフッ素を含有する誘導体、調製するための工程、並びに使用 | |
| JP2003063994A (ja) | アルツハイマー病およびパーキンソン病に関連する痴呆または認識障害のための組合せ治療 | |
| JP2001072604A (ja) | 哺乳動物におけるニコチン嗜癖の予防及び治療用医薬組成物 | |
| TW200300139A (en) | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome | |
| KR20040029356A (ko) | 니코틴 수용체 부분 길항제 및 항구토제를 포함하는 콜린 작용을 조절하기 위한 약학 조성물 | |
| US20050250806A1 (en) | Nicotinic acetylcholine receptor antagonists in the treatment of restless legs syndrome | |
| US11505555B2 (en) | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | |
| JP2002012558A (ja) | 肥満の治療又は体重の減少を容易にし又は促進するための医薬組成物 | |
| CA2754416A1 (fr) | Nouveau medicament pour le traitement de maladie cognitive | |
| SK14502000A3 (sk) | Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu | |
| JPH0672098B2 (ja) | コカイン、アンフェタミンおよびフェンシクリジン拮抗物質としての徐放性（強固結合性）ドーパミン、セロトニンまたはノルエピネフリン再取込阻害剤 | |
| TWI364280B (en) | Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6h)-one for treating diseases, disorers or passive cutaneous anaphylaxis through histamine h receptor antagonism effect | |
| JP2021530557A (ja) | トラジピタントを用いる処置方法 | |
| TW201033198A (en) | Pharmacokinetically-based dosing regimens of a thrombin receptor antagonist | |
| CA2489791A1 (fr) | Combinaisons d'inhibiteurs de pde-v et d'antagonistes du recepteur nk1 pour le traitement de l'anxiete ou de la depression | |
| WO2021023813A1 (fr) | Composés de 5-hétéroaryl-pyridin-2-amine en tant qu'antagonistes du récepteur du neuropeptide ff | |
| RU2334747C1 (ru) | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| MX2007008323A (es) | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente benzodiazepinico. | |
| EA040488B1 (ru) | Производные бензодиазепина, композиции и способы лечения когнитивного нарушения |